Anterix Inc.
ATEX· Nasdaq
Filed Jun 14, 2023 · 10-K · 75 days after period end · 0001304492-23-000030
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021 | Q4 2020 |
|---|---|---|---|---|
| Revenue | $608.00K | $335.00K | $181.00K | $327.00K |
| Net Income | $15.54M | -$11.02M | -$10.94M | -$11.74M |
| EPS Diluted | — | — | -$0.62 | -$0.68 |
Anterix Inc. · CIK 1304492 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Mar 31, 2023 · filed Jun 14, 2023 · 75 d after period end